Smart Detect™ SARS-CoV-2 rRT-PCR Kit
FDA Emergency Use Authorized
Smart DetectTM SARS-CoV-2 rRT-PCR Kit is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) in human nasopharyngeal swab, anterior nasal swab and mid-turbinate nasal swab specimens from individuals suspected of COVID-19 by their healthcare provider. Clinical laboratories that are certified under Clinical Laboratory Improvement Amendments (CLIA) of 1988, 42 U.S.C. §263a, to perform high complexity tests in the U.S. can immediately begin using this kit, which offers results in about 4 hours.
Please click here for Frequently Asked Questions.
More Information (click Downloads button below)
- Letter of Authorization
- Package Insert (English/Spanish)
- Patient Fact Sheet
- Health Care Provider Fact Sheets